Early evidence suggests BPC 157 repairs tissue rather than just dulling symptoms. To read more, tap the link in bio. The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 and Healing Peptides: Hype or Hope? A Doctor's Comprehensive Perspective MSK Doctor Zaid Matti Peptides in the Limelight: US FDA May Ease Restrictions on Several Peptides The Dermatology Digest FDA to weigh easing limits on unproven peptides The FDA's Current Position on Peptides Explained Holt Law